The use of small interfering RNAs (siRNAs) has been under investigation for the treatment of
several unmet medical needs, including acute lung injury/acute respiratory distress …

Mortality in acute respiratory distress syndrome (ARDS) remains unacceptably high at
approximately 39%. One of the only treatments is supportive: mechanical ventilation …

Background The global numbers of confirmed cases and deceased critically ill patients with
COVID-19 are increasing. However, the clinical course, and the 60-day mortality and its …

Background A COVID-19 outbreak started in Wuhan, China, last December and now has
become a global pandemic. The clinical information in caring of critically ill patients with …

Objectives: The goal of this study was to determine the role of microRNA transfer in
mediating the effects of mesenchymal stem cell–derived extracellular vesicles in acute lung …

OBJECTIVES: Age-specific definitions for acute respiratory distress syndrome (ARDS) are
available, including a specific definition for neonates (the “Montreux definition”). The …

While effective treatments for acute respiratory distress syndrome (ARDS) are lacking,
mechanical lung ventilation can sustain adequate gas exchange in critically ill patients with …

Acute respiratory distress syndrome (ARDS) is driven by a severe pro-inflammatory
response resulting in lung damage, impaired gas exchange and severe respiratory failure …

Acute respiratory distress syndrome (ARDS) causes a heterogeneous lung injury and
remains a serious medical problem, with one of the only treatments being supportive care in …

Aerosol therapy is a key modality for drug delivery to the lungs of respiratory disease
patients. Aerosol therapy improves therapeutic effects by directly targeting diseased lung …